AVXL
Anavex Life Sciences Corporation
-22.55%
$11.75 - $9.10
Feb 7th 2023 - Mar 21st 2023
Mar, 17, 2023
It can be shown that treatment bringing back indep... See more
Feb, 16, 2023
$AVXL This may show why Anavex is definitely on th... See more
SAVA
Cassava Sciences Inc
-13.96%
$29.88 - $25.71
Feb 7th 2023 - Mar 21st 2023
Mar, 15, 2023
$SAVA “Treatment also eased depression and dementi... See more
Feb, 1, 2023
This will bring in billions of revenue and it will... See more
Mar, 17, 2023
It can be shown that treatment bringing back independence is less costly than the nursing homes and medical staff.
Feb, 16, 2023
$AVXL This may show why Anavex is definitely on the right path by using patients personal genetics to determine dosage.
Feb, 16, 2023
Pill = best possible treatment course.
Feb, 14, 2023
Many claim him to be selfish and unconcerned with others, I see a different Missling, with humility and a deep concern for patients who are suffering.
Jan, 24, 2023
Half the patients improved over baseline over 1 year.
Jan, 24, 2023
Blarcamesine’s Phase III clinical trials show similar levels of significant improvement in communication and interaction, as patients had statistically significant improvement in the RSBQ primary endpoint of 72.2% compared to 38.5% on placebo. .
Jan, 22, 2023
And better still for just those 85% carrying the normal SigmaR1 gene as well as for APOE2 and 3 patients.
Jan, 18, 2023
new clinical trial results show great promise for treating early Alzheimer’s, giving renewed hope for effective treatments.
Jan, 17, 2023
Anavex has over 760 patients that have taken it without any significant issues. .
Mar, 15, 2023
$SAVA “Treatment also eased depression and dementia-related behaviors in patients, two exploratory trial goals, and simufilam was found to be safe and well tolerated.”
Feb, 1, 2023
This will bring in billions of revenue and it will make the life quality longer for AD patients.
Jan, 29, 2023
This sub-set of patients improved -4.96 mean points on ADAS-Cog from baseline to month 12.
Jan, 18, 2023
CURING LEUKEMIA isn't a fly by night thing with Gamma T Cells and they already have ONE COMPLETE RESPONSE curing someone in Stage 4 nonresponsive to other treatments!
Jan, 11, 2023
$SAVA this is going to be game changer and first drug to give some relief to AD patients … and will make $BIIB poison AD pills an obsolete
Jan, 9, 2023
The high number of the patients that went into CMS (which is 80% complete) is reassuring.
Jan, 6, 2023
but reverses cognitive decline and improves quality of life for the patient AND the FAMILY!
Dec, 30, 2022
but mostly new hope for all the families and patients with AZ.
Dec, 29, 2022
Testing still continues, so in my way of thinking the real-world results in patients must be nothing short of excellent.
Feb, 1, 2023
$PALI patients ⏰⏰⏰
Jan, 23, 2023
$PALI patients are in high gear 🤑🤑🤑
Oct, 5, 2022
Conclusion: For patients undergoing elective bowel resection surgery, LB1148 was safe and well-tolerated and significantly accelerated the return of bowel function.